Trinity Biotech rotavirus test approved in Germany:
This article was originally published in Clinica
Executive Summary
Trinity Biotech's diagnostic test for Rotavirus has been approved by the Paul Ehrlich Institute for use in Germany. The test is an enzyme immunoassay which detects the presence of Rotavirus within several hours. The test has also been submitted for approval in the US and Trinity has responded to the FDA's comments on the submission. More than three million cases of Rotavirus infection occur in the US each year.